The Plasma Concentration of Medroxyprogesterone Acetate and Ovarian Function During Treatment with Medroxyprogesterone Acetate in 5 and 10 mg Doses

@article{Wikstrm1984ThePC,
  title={The Plasma Concentration of Medroxyprogesterone Acetate and Ovarian Function During Treatment with Medroxyprogesterone Acetate in 5 and 10 mg Doses},
  author={A. Wikstr{\"o}m and B. Green and E. Johansson},
  journal={Acta Obstetricia et Gynecologica Scandinavica},
  year={1984},
  volume={63}
}
Abstract. Peripheral plasma levels of medroxyprogesterone acetate (MPA) were determined by radioimmunoassay in 5 women after oral administration of 5 and 10 mg medroxyprogesterone acetate daily. Peak levels of MPA in plasma were recorded within 1‐3 hours of taking the tablet, which indicates a rapid absorption from the gastro‐intestinal tract. The levels of medroxyprogesterone acetate 12 hours after taking of the 5 mg tablet‐remained constant throughout the 8 weeks of study. Peripheral plasma… Expand
The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation.
Pharmacokinetics of oestrogens and progestogens.
...
1
2
3
...

References

SHOWING 1-10 OF 17 REFERENCES
...
1
2
...